Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient

NCT: NCT05456750 · COMPLETED

NCT IDNCT05456750
StatusCOMPLETED
Start Date2022-07-28
Completion2024-08-31
SponsorTri-Service General Hospital (TSGH) (OTHER)
First posted
Last updated

Brief Summary

The aim of our study is to therapeutic effect after intravenous laser irradiation of blood for ischemic stroke patient

Frequently Asked Questions

What is the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient?

the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient is a clinical trial registered under NCT05456750. Current status: COMPLETED.

What is the status of NCT05456750?

The current status of NCT05456750 (the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient) is: COMPLETED.

When did the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient start?

the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient started on 2022-07-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.